194 related articles for article (PubMed ID: 33674633)
1. Circulating miR-21, miR-29a, and miR-126 are associated with premature death risk due to cancer and cardiovascular disease: the JACC Study.
Yamada H; Suzuki K; Fujii R; Kawado M; Hashimoto S; Watanabe Y; Iso H; Fujino Y; Wakai K; Tamakoshi A
Sci Rep; 2021 Mar; 11(1):5298. PubMed ID: 33674633
[TBL] [Abstract][Full Text] [Related]
2. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs in association with pancreatic cancer risk within 5 years.
Wang C; Cai H; Cai Q; Wu J; Stolzenberg-Solomon R; Guo X; Zhu C; Gao YT; Berlin J; Ye F; Zheng W; Setiawan VW; Shu XO
Int J Cancer; 2024 Aug; 155(3):519-531. PubMed ID: 38602070
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease.
Zhang L; Zhang Y; Xue S; Ding H; Wang Y; Qi H; Wang Y; Zhu W; Li P
J Cell Mol Med; 2020 Jan; 24(1):1146-1150. PubMed ID: 31709737
[TBL] [Abstract][Full Text] [Related]
6. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer.
ZiaSarabi P; Sorayayi S; Hesari A; Ghasemi F
J Cell Biochem; 2019 Aug; 120(8):12376-12381. PubMed ID: 30861177
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
[TBL] [Abstract][Full Text] [Related]
10. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
[TBL] [Abstract][Full Text] [Related]
12. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
[TBL] [Abstract][Full Text] [Related]
13. [Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma].
Xu YN; Xiao CR; Huang YD; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):471-475. PubMed ID: 28446295
[TBL] [Abstract][Full Text] [Related]
14. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
[TBL] [Abstract][Full Text] [Related]
15. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
[TBL] [Abstract][Full Text] [Related]
17. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia.
Yamada A; Cox MA; Gaffney KA; Moreland A; Boland CR; Goel A
PLoS One; 2014; 9(11):e112481. PubMed ID: 25405754
[TBL] [Abstract][Full Text] [Related]
18. A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer.
Zhang Y; Roth JA; Yu H; Ye Y; Xie K; Zhao H; Chang DW; Huang M; Li H; Qu J; Wu X
Carcinogenesis; 2019 Jul; 40(5):643-650. PubMed ID: 30428030
[TBL] [Abstract][Full Text] [Related]
19. Plasma MicroRNA-34a as a Potential Biomarker for Early Diagnosis of Esophageal Cancer.
Lin Y; Lin Z; Fang Z; Li H; Zhi X; Zhang Z
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710448
[TBL] [Abstract][Full Text] [Related]
20. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
